#  Nazlee Zebardast, MD, MSc Awarded NIH K Grant for Glaucoma Risk Prediction Research  

 





November 12, 2021

 

 

   ![Nazlee Zebardast Headshot](/sites/g/files/omnuum9886/files/styles/hwp_1_1__360x360_scale/public/eye/files/zebardast_nazlee_220_x_220_01.jpg?itok=1WIo1d1c) 

 

Glaucoma is a progressive, irreversible optic neuropathy with variable presentation and clinical course and there is currently no way to pre-symptomatically distinguish patients at risk of severe and progressive disease from those individuals unlikely to develop glaucoma-related vision loss.  [Nazlee Zebardast, MD, MSc](/nazleezebardast), Assistant Professor of Ophthalmology at Harvard Medicial School and Director of Glaucoma Imaging at Mass Eye and Ear, has been awarded a five-year $1,339,246.00 K23 grant from the National Eye Institute to use cutting edge machine learning integration of image-based phenotypes and genetic associations to discover novel disease related genetic associations, and test their utility for identifying glaucoma cases in independent cohorts. Dr. Zebardast ultimately hopes to develop a precision medicine approach using imaging and genetic features to improve our assessment of disease risk for any individual.



 

 

 



 

 See also:- [ Grants ](/news-categories/grants)
 
 

 Share on:- [     Facebook ](#)
- [     Twitter ](#)
- [     Linkedin ](#)